Sector

US drug shortages rekindle pharma recovery hopes

Drug shortages have increased in the US amid supply chain and manufacturing constraints. Domestic sales are growing too

HCL Tech Q4 FY23 – Navigated the troubled macro well

For HCL Tech, decent deal win, steady hiring, and realistic guidance marked the quarter

Hospital sector likely to firm up on higher occupancy, favourable base in Q4

Most brokerages anticipate that the trend of capacity expansion will persist throughout the sector. Investor attention will remain focused on management commentaries for insights into plans to expand capacity, as well as the potential impact of this on profitability and margins.

Diagnostics: Time to look at this quasi-consumer industry

A bigger landscape of opportunity awaits organised diagnostic chains to increase market share

Chart of the Day: ISG index predicts more pain for as-a-service IT companies

Contract awards in the as-a-service market declined 13 percent in March 2023 quarter but IT services are expected to fare relatively better

For Infosys and TCS, the COVID boom is ending without profit margin repair

The FY24 profit margins of Infosys and TCS are lower than in pre COVID years 

Infosys Q4 FY23 – What’s the right level to bottom-fish after a complete washout?

A correction of over 12 percent from the current level can be a good entry point for long-term gains

Highest risk, maximum reward in healthcare lies in diagnostics, says Incred PMS' Aditya Khemka

For investors in hospital stocks, Khemka says the right time for entry is when the company has completed its capex, because the downside potential from that level is less, while the upside is good.

Par or sub-par monsoon? — Bracing for the worst case!

Deficient rains can be a bane for agri- and rural-centric companies, while a boon for sectors that offer respite from scorching heat

Chart of the Day: Railway freight traffic growth changes to the normal track

Freight traffic growth slowed to 3.5 percent in the second half of FY23 from 10.1 percent in H1 FY23

Discovery Series: Krsnaa Diagnostics -- Multiple catalysts at work

Business fundamentals look solid and the growth potential is very promising

Supply glut clouds sales outlook for agrochem companies

After FMC Corp, Bayer has projected slower growth in calendar year 2023

Power Grid flexes its muscles in competitive bids

The company has won majority of the projects awarded through tariff based competitive bidding (TBCB) in FY23

Chart of the day: Fertiliser subsidy may drop below budget estimates in FY24

The fall in raw material prices accelerated since the Union Budget on February 1

Investors should mind the difference between Accenture and Indian IT firms

Accenture is more diversified than India listed IT firms

Coromandel International marks strategic entry into new growth segments

A stock well positioned to benefit from the growth potential in agrochemical/industrial chemical space

India’s life insurers to get the last hurrah on growth before flatlining

The month of March could show sharp business growth for life insurers as Indians make their final dash to secure tax-free insurance policies before new rules kick in 

Economic fallout of banking crisis a bigger risk for IT sector

If the banking turmoil adds to consumers’ anxiety about future incomes, it could trigger a deeper economic slowdown  

A hospital stock with best-in-class operating numbers, growth template

Aggressive long-term expansion plans are in place with brownfield projects to be margin accretive for Max Healthcare in the near term

Why this high-quality midcap deserves a look

With the economy gaining momentum and supply challenges abating, Control Print is poised for strong growth

Chart of the Day | Electricity demand exceeds FY22 levels in 11 months 

Electricity usage projected to scale new highs in April 2023 

Brokerage firm Nirmal Bang sees favourable risk-reward in pharma

Pharma companies are likely to experience a recovery in margins, thanks to the easing of raw material costs and a reduction in price erosion in the US market.

Three charts that illustrate the US banking crisis

The markets are pricing in a 100 basis point cut in the Fed Funds rate in one year 

TCS' CEO exit makes leadership changes a key factor to watch

If he retired from TCS, Rajesh Gopinathan's tenure would have lasted for 13 more years. The new CEO's tenure will be for 7-8 years before he reaches retirement age